2nyy
From Proteopedia
(New page: 200px<br /> <applet load="2nyy" size="450" color="white" frame="true" align="right" spinBox="true" caption="2nyy, resolution 2.61Å" /> '''Crystal structure o...) |
|||
| Line 1: | Line 1: | ||
| - | [[Image:2nyy. | + | [[Image:2nyy.jpg|left|200px]]<br /><applet load="2nyy" size="350" color="white" frame="true" align="right" spinBox="true" |
| - | <applet load="2nyy" size=" | + | |
caption="2nyy, resolution 2.61Å" /> | caption="2nyy, resolution 2.61Å" /> | ||
'''Crystal structure of botulinum neurotoxin type A complexed with monoclonal antibody CR1'''<br /> | '''Crystal structure of botulinum neurotoxin type A complexed with monoclonal antibody CR1'''<br /> | ||
| Line 8: | Line 7: | ||
==About this Structure== | ==About this Structure== | ||
| - | 2NYY is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Clostridium_botulinum Clostridium botulinum] with ZN and CA as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http:// | + | 2NYY is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Clostridium_botulinum Clostridium botulinum] with <scene name='pdbligand=ZN:'>ZN</scene> and <scene name='pdbligand=CA:'>CA</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2NYY OCA]. |
==Reference== | ==Reference== | ||
| Line 23: | Line 22: | ||
[[Category: protein antibody complex]] | [[Category: protein antibody complex]] | ||
| - | ''Page seeded by [http:// | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 17:40:00 2008'' |
Revision as of 15:40, 15 February 2008
|
Crystal structure of botulinum neurotoxin type A complexed with monoclonal antibody CR1
Overview
Broadening antibody specificity without compromising affinity should, facilitate detection and neutralization of toxin and viral subtypes. We, used yeast display and a co-selection strategy to increase, cross-reactivity of a single chain (sc) Fv antibody to botulinum, neurotoxin type A (BoNT/A). Starting with a scFv that binds the BoNT/A1, subtype with high affinity (136 pM) and the BoNT/A2 subtype with low, affinity (109 nM), we increased its affinity for BoNT/A2 1,250-fold, to 87, pM, while maintaining high-affinity binding to BoNT/A1 (115 pM). To find, the molecular basis for improved cross-reactivity, we determined the X-ray, co-crystal structures of wild-type and cross-reactive antibodies complexed, to BoNT/A1 at resolutions up to 2.6 A, and measured the thermodynamic, contribution of BoNT/A1 and A2 amino acids to wild-type and cross-reactive, antibody binding. The results show how an antibody can be engineered to, bind two different antigens despite structural differences in the, antigen-antibody interface and may provide a general strategy for tuning, antibody specificity and cross-reactivity.
About this Structure
2NYY is a Single protein structure of sequence from Clostridium botulinum with and as ligands. Full crystallographic information is available from OCA.
Reference
Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin., Garcia-Rodriguez C, Levy R, Arndt JW, Forsyth CM, Razai A, Lou J, Geren I, Stevens RC, Marks JD, Nat Biotechnol. 2007 Jan;25(1):107-16. Epub 2006 Dec 17. PMID:17173035
Page seeded by OCA on Fri Feb 15 17:40:00 2008
